At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Study of Lipoprotein (a) Levels in Patients with Cardiovascular Disease

Clinical Trial Title: 
Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels in patients with established CVD.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Annabelle S. Volgman, MD
Clinical Trial Protocol Description: 

Lipoprotein (a) is now recognized as a causal risk factor for coronary artery disease, stroke, and peripheral artery disease. The purpose of this study is to improve knowledge regarding the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD). Relevant demographic data, medical history, and laboratory values for LDL-cholesterol and Lp(a) will be collected retrospectively. In the event that laboratory data is not available blood sampling will be performed.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are between 18 and 80 years of age.
  • Have established cardiovascular disease (CVD) defined as one of the following:
    • Have a history of a myocardial infarction (MI).
    • Have a history of ischemic stroke.
    • Have symptomatic PAD.

You will be excluded from the study if any of the following criteria apply to you:

  • Are enrolled in a clinical study with investigational drugs.

This is a partial list of inclusion and exclusion criteria. To inquire about your eligibility, please call the contact number provided.

Clinical Trial Area: 
Heart and Vascular Conditions
Contact Phone: 
(312) 942-8144
Contact Name: 
Jennifer Fernandez